PT1608655E - Derivados pirroimidazole, a sua preparação, composições farmacêuticas contendo-os, e sua utilização como agentes nootrópicos - Google Patents

Derivados pirroimidazole, a sua preparação, composições farmacêuticas contendo-os, e sua utilização como agentes nootrópicos Download PDF

Info

Publication number: PT1608655E
Authority: PT; Portugal
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; nootropic agents; action
Prior art date: 2003-03-24

Application number

PT04741432T

Other languages

English (en)

Inventor

Stefania Gagliardi

Carlo Farina

Carlo Parini

Marisa Martinelli

Carla Ghelardini

Original Assignee

Brane Discovery Srl In Liquida

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-24

Filing date

2004-03-22

Publication date

2008-10-07

2004-03-22 Application filed by Brane Discovery Srl In Liquida filed Critical Brane Discovery Srl In Liquida

2008-10-07 Publication of PT1608655E publication Critical patent/PT1608655E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT04741432T 2003-03-24 2004-03-22 Derivados pirroimidazole, a sua preparação, composições farmacêuticas contendo-os, e sua utilização como agentes nootrópicos PT1608655E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000573A ITMI20030573A1 (it)	2003-03-24	2003-03-24	Composti ad azione nootropica, loro preparazione,

Publications (1)

Publication Number	Publication Date
PT1608655E true PT1608655E (pt)	2008-10-07

Family

ID=33042696

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT04741432T PT1608655E (pt)	2003-03-24	2004-03-22	Derivados pirroimidazole, a sua preparação, composições farmacêuticas contendo-os, e sua utilização como agentes nootrópicos

Country Status (23)

Country	Link
US (3)	US7544705B2 (pt)
EP (1)	EP1608655B8 (pt)
JP (1)	JP4920408B2 (pt)
CN (1)	CN100522963C (pt)
AT (1)	ATE401327T1 (pt)
AU (1)	AU2004224087B2 (pt)
BR (1)	BRPI0408601A (pt)
CA (1)	CA2520008C (pt)
CY (1)	CY1108401T1 (pt)
DE (1)	DE602004015089D1 (pt)
DK (1)	DK1608655T3 (pt)
EA (1)	EA009558B1 (pt)
ES (1)	ES2309534T3 (pt)
HR (1)	HRP20050833A2 (pt)
IT (1)	ITMI20030573A1 (pt)
NO (1)	NO20054898L (pt)
NZ (1)	NZ543154A (pt)
PL (2)	PL1608655T3 (pt)
PT (1)	PT1608655E (pt)
RS (1)	RS20050725A (pt)
SI (1)	SI1608655T1 (pt)
WO (1)	WO2004085438A2 (pt)
ZA (1)	ZA200508578B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20030573A1 (it) *	2003-03-24	2004-09-25	Nikem Research Srl	Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) *	2006-11-15	2008-05-28	Nikem Research S.R.L.	Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
ITMI20070770A1 (it)	2007-04-16	2008-10-17	Brane Discovery S R L	Impiego di dimiracetam nel trattamento del dolore cronico
AU2012201853B2 (en) *	2007-04-16	2013-06-27	Neurotune Ag	Use of dimiracetam in the treatment of chronic pain
CA2740610C (en) *	2008-10-16	2020-01-07	The Johns Hopkins University	Synaptic vesicle protein 2a inhibitors for treating age-related cognitive impairment
US9125898B2 (en)	2008-11-14	2015-09-08	Neurotune Ag	Acetam derivatives for pain relief
CN102905532A (zh) *	2010-02-09	2013-01-30	约翰斯.霍普金斯大学	用于改善认知功能的方法和组合物
PL2598504T3 (pl) *	2010-07-26	2014-10-31	Neurotune Ag	Sposób otrzymywania dimiracetamu
HK1215170A1 (zh)	2012-11-14	2016-08-19	The Johns Hopkins University	治療精神分裂症的方法和組合物
CA2904767C (en)	2013-03-15	2022-06-21	Agenebio, Inc.	Methods and compositions for improving cognitive function
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
EA034167B8 (ru)	2015-05-22	2021-04-27	Эйджинбайо, Инк.	Фармацевтические композиции леветирацетама пролонгированного высвобождения
JOP20190251A1 (ar)	2017-05-31	2019-10-21	Metys Pharmaceuticals AG	تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
AU2019394706A1 (en)	2018-12-04	2021-05-20	Metys Pharmaceuticals AG	Synergistic compositions comprising R-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones and S-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones in a non-racemic ratio
BR112021010739A2 (pt)	2018-12-04	2021-08-24	Metys Pharmaceuticals AG	Composições sinérgicas compreendendo (r)-(2-(2-oxopirrolidina-1-il)butanamida e (s)-2-(2-oxopirrolidina-1-il)butanamida) em uma proporção não racêmica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4582838A (en) *	1984-08-24	1986-04-15	Warner-Lambert Company	Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators
IT1233860B (it) *	1988-02-08	1992-04-21	Isf Spa	Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
US5200406A (en) *	1988-02-08	1993-04-06	I.S.F. Societa Per Azioni	Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
JP3400466B2 (ja) *	1991-10-28	2003-04-28	日本水産株式会社	高純度エイコサペンタエン酸またはそのエステルの製造方法
GB9123641D0 (en)	1991-11-07	1992-01-02	Isf Spa	Process
ITMI20030573A1 (it) *	2003-03-24	2004-09-25	Nikem Research Srl	Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) *	2006-11-15	2008-05-28	Nikem Research S.R.L.	Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

2003
- 2003-03-24 IT IT000573A patent/ITMI20030573A1/it unknown
2004
- 2004-03-22 SI SI200430868T patent/SI1608655T1/sl unknown
- 2004-03-22 HR HR20050833A patent/HRP20050833A2/hr not_active Application Discontinuation
- 2004-03-22 AT AT04741432T patent/ATE401327T1/de not_active IP Right Cessation
- 2004-03-22 PL PL04741432T patent/PL1608655T3/pl unknown
- 2004-03-22 WO PCT/EP2004/050339 patent/WO2004085438A2/en not_active Ceased
- 2004-03-22 BR BRPI0408601-5A patent/BRPI0408601A/pt not_active Application Discontinuation
- 2004-03-22 CA CA2520008A patent/CA2520008C/en not_active Expired - Fee Related
- 2004-03-22 PL PL378939A patent/PL378939A1/pl unknown
- 2004-03-22 JP JP2006505479A patent/JP4920408B2/ja not_active Expired - Fee Related
- 2004-03-22 DK DK04741432T patent/DK1608655T3/da active
- 2004-03-22 RS YUP-2005/0725A patent/RS20050725A/sr unknown
- 2004-03-22 CN CNB2004800055916A patent/CN100522963C/zh not_active Expired - Fee Related
- 2004-03-22 AU AU2004224087A patent/AU2004224087B2/en not_active Ceased
- 2004-03-22 ES ES04741432T patent/ES2309534T3/es not_active Expired - Lifetime
- 2004-03-22 US US10/550,483 patent/US7544705B2/en not_active Expired - Fee Related
- 2004-03-22 NZ NZ543154A patent/NZ543154A/en unknown
- 2004-03-22 DE DE602004015089T patent/DE602004015089D1/de not_active Expired - Lifetime
- 2004-03-22 EP EP04741432A patent/EP1608655B8/en not_active Expired - Lifetime
- 2004-03-22 EA EA200501501A patent/EA009558B1/ru not_active IP Right Cessation
- 2004-03-22 PT PT04741432T patent/PT1608655E/pt unknown
2005
- 2005-10-21 ZA ZA200508578A patent/ZA200508578B/en unknown
- 2005-10-24 NO NO20054898A patent/NO20054898L/no not_active Application Discontinuation
2008
- 2008-10-08 CY CY20081101113T patent/CY1108401T1/el unknown
2009
- 2009-02-13 US US12/378,475 patent/US7732473B2/en not_active Expired - Fee Related
2010
- 2010-02-17 US US12/658,973 patent/US20100173945A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP4920408B2 (ja)	2012-04-18
ZA200508578B (en)	2007-04-25
SI1608655T1 (sl)	2008-12-31
ITMI20030573A1 (it)	2004-09-25
EA009558B1 (ru)	2008-02-28
EP1608655B8 (en)	2008-10-15
PL378939A1 (pl)	2006-06-12
WO2004085438A2 (en)	2004-10-07
NO20054898L (no)	2005-10-24
HRP20050833A2 (en)	2006-02-28
RS20050725A (sr)	2007-11-15
US7732473B2 (en)	2010-06-08
ATE401327T1 (de)	2008-08-15
CN100522963C (zh)	2009-08-05
CA2520008A1 (en)	2004-10-07
CY1108401T1 (el)	2014-02-12
DK1608655T3 (da)	2008-11-03
AU2004224087B2 (en)	2010-04-01
EA200501501A1 (ru)	2006-04-28
CA2520008C (en)	2011-08-23
AU2004224087A1 (en)	2004-10-07
EP1608655B1 (en)	2008-07-16
ES2309534T3 (es)	2008-12-16
US20090163565A1 (en)	2009-06-25
US7544705B2 (en)	2009-06-09
US20100173945A1 (en)	2010-07-08
CN1756757A (zh)	2006-04-05
EP1608655A2 (en)	2005-12-28
WO2004085438A3 (en)	2004-11-25
DE602004015089D1 (de)	2008-08-28
HK1083837A1 (en)	2006-07-14
JP2006523198A (ja)	2006-10-12
PL1608655T3 (pl)	2009-03-31
NZ543154A (en)	2008-03-28
US20070027137A1 (en)	2007-02-01
BRPI0408601A (pt)	2006-03-07

Publication	Publication Date	Title
PL1608655T3 (pl)	2009-03-31	Pochodne piroloimidazolowe, ich wytwarzanie, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako środków o działaniu nootropowym
EA200601212A1 (ru)	2006-10-27	Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
TNSN04113A1 (en)	2006-06-01	3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MXPA05007462A (es)	2006-01-27	Derivados de pirrolopiridazina.
AU2004263179A8 (en)	2011-07-14	Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
ZA200706029B (en)	2008-12-31	Tricyclic &-opioid domulators
WO2005004802A3 (en)	2005-09-22	N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
MY140488A (en)	2009-12-31	Substituted oxazolidinones and their use in the field of blood coagulation
ATE442142T1 (de)	2009-09-15	Fredericamycin-derivate als arzneimittel zur tumorbehandlung
TW200716546A (en)	2007-05-01	Oxindole compounds and their uses as therapeutic agents
CA2473070A1 (en)	2003-07-31	Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
IL181700A0 (en)	2007-07-04	Quinazoline derivatives and pharmaceutical compositions containing the same
IL176110A0 (en)	2006-10-05	Azabicyclic heterocycles as cannabinoid receptor modulators
TW200724543A (en)	2007-07-01	Heterocyclic compounds and their uses as therapeutic agents
WO2004110376A3 (en)	2005-02-24	Ccr-2 antagonists for treatment of neuropathic pain
UA86024C2 (ru)	2009-03-25	Трициклические дельта-опиоидные модуляторы
YU75603A (sh)	2006-05-25	Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja
IL175819A0 (en)	2006-10-05	Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
MXPA06014182A (es)	2007-06-25	Nucleosidos de 3-??-d-ribofuranosiltiazolo[4,5-d]piridimina y usos de los mismos.
MX2008002234A (es)	2008-03-27	Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.
MXPA06007007A (es)	2007-06-08	Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
TW200621767A (en)	2006-07-01	Tricyclic δ-opioid modulators
WO2002076930A3 (en)	2003-01-16	Substituted diarylureas as stimulators for fas-mediated apoptosis
SG146685A1 (en)	2008-10-30	Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
GB0522908D0 (en)	2005-12-21	Therapeutic agents